Viread Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Conditions:   Patient Satisfaction;   Drug Adherence;   Efficacy, Self;   Safety Issues Intervention:   Drug: tenofovir alafenamide (TAF) Sponsor:   Taichung Veterans General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2022 Category: Research Source Type: clinical trials